These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28388387)

  • 21. Treatment of Helicobacter pylori infection: Where are we now?
    Liou JM; Wu MS; Lin JT
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinician's guide to salvage therapy for persistent Helicobacter pylori infection.
    Luther J; Chey WD; Saad RJ
    Hosp Pract (1995); 2011 Feb; 39(1):133-40. PubMed ID: 21441768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H. pylori Infection: ACG Updates Treatment Recommendations.
    Randel A
    Am Fam Physician; 2018 Jan; 97(2):135-137. PubMed ID: 29365220
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quadruple therapy is more effective against H. pylori].
    Oberhofer E
    MMW Fortschr Med; 2016 May; 158(9):20. PubMed ID: 27155683
    [No Abstract]   [Full Text] [Related]  

  • 25. [Successful eradication of
    Gao HJ; Zhan BJ
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2336-2339. PubMed ID: 32791807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
    Sarikaya M; Filik L; Doğan Z; Ergül B
    Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
    [No Abstract]   [Full Text] [Related]  

  • 27. Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
    Frem JC; Gold BD; Shehata BM; Cole CR
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):589-92. PubMed ID: 18493216
    [No Abstract]   [Full Text] [Related]  

  • 28. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
    Gisbert JP; McNicholl AG
    Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
    [No Abstract]   [Full Text] [Related]  

  • 29. [Helicobacter pylori: what schemes of eradication are essential today?].
    Maev IV; Samsonov AA; Golubev NN
    Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
    Dang BN; Graham DY
    Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(7):383-384. PubMed ID: 28465548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Helicobacter pylori infection in patients with functional dyspepsia, eradication rates in the Donetsk region].
    Dorofeev AÉ; Rudenko NN; Agibalov AN; Kugler TE; Sibilev AV; Tomash OV
    Lik Sprava; 2014 Nov; (11):119-22. PubMed ID: 25528848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Helicobacter pylori infection 2016.
    O'Connor A; Fischbach W; Gisbert JP; O'Morain C
    Helicobacter; 2016 Sep; 21 Suppl 1():55-61. PubMed ID: 27531541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.
    Gisbert JP;
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1484-5; author reply 1486. PubMed ID: 22582841
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
    Dos Santos AA; Carvalho AA
    World J Gastroenterol; 2015 Jan; 21(1):139-54. PubMed ID: 25574087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study.
    Fagoonee S; Astegiano M; Smedile A; Pellicano R
    Panminerva Med; 2013 Sep; 55(3):309-10. PubMed ID: 24088806
    [No Abstract]   [Full Text] [Related]  

  • 37. [Benefit/risk assessment and issues related to antibiotic use of
    Wang JB
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2343-2345. PubMed ID: 32791809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of probiotics in Helicobacter pylori eradication therapy.
    Medeiros JA; Pereira MI
    J Clin Gastroenterol; 2013 Jan; 47(1):1-5. PubMed ID: 23222208
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].
    Jeong MH; Chung JW; Lee SJ; Ha M; Jeong SH; Na S; Na BS; Park SK; Kim YJ; Kwon KA; Ko KI; Jo Y; Hahm KB; Jung HY
    Korean J Gastroenterol; 2012 Jun; 59(6):401-6. PubMed ID: 22735872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
    Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
    Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.